Nyra Medical Announces Initiation of First-in-Human Clinical Trial for Novel Mitral Valve Repair Device

Nyra Medical Announces Initiation of First-in-Human Clinical Trial for Novel Mitral Valve Repair Device

ATLANTA, Oct. 22, 2025 /PRNewswire/ -- Nyra Medical, a leading innovator in structural heart therapies, announced today the initiation of its first-in-human clinical study evaluating its novel Cardiac Leaflet Enhancer (CARLEN™) System in patients with functional (secondary) mitral regurgitation (FMR).

Nyra Medical commences trial of CARLEN system for FMR

Nyra Medical has commenced a trial to test its new Cardiac Leaflet Enhancer (CARLEN) system in individuals with FMR.The post Nyra Medical commences trial of CARLEN system for FMR appeared first on Medical Device Network.

Nyra Medical Initiates First-in-Human Clinical Trial for Mitral Valve Repair Device

Nyra Medica has announced the initiation of its first-in-human clinical study evaluating its novel Cardiac Leaflet Enhancer System in patients with functional (secondary) mitral regurgitation.

First-in-human study of Cardiac Leaflet Enhancer reaches enrolment milestone

Nyra Medical Nyra Medical has announced the initiation of its first-in-human clinical study evaluating its novel Cardiac Leaflet Enhancer (CARLEN) system in patients with functional (secondary) mitral regurgitation (FMR). The study, focused on clinical safety and technical performance, has enrolled more than 10 patients, many with at least thirty-day follow-up to date. Nyra Medical’s proprietary transcatheter technology is designed to repair FMR…